https://www.fool.com/investing/2024/09/30/15-best-dividend-stocks-for-lifelong-passive-incom/?source=iedfolrf0000001
Sep 30, 2024 - These 15 dividend stocks can deliver stable passive income for life.
0
fool:-2540263007444350302
0
https://www.fool.com/investing/2024/09/28/3-surprisingly-underrated-stocks-to-buy-right-now/?source=iedfolrf0000001
Sep 28, 2024 - These stocks might look like bad picks. But appearances can be deceiving.
0
fool:-7567214222034802602
0
https://www.fool.com/investing/2024/09/23/2-beaten-down-stocks-to-buy-and-hold-for-a-decade/?source=iedfolrf0000001
Sep 23, 2024 - These innovative companies have the tools to rebound.
0
fool:-4843406609689065949
0
https://www.fool.com/investing/2024/09/21/3-dirt-cheap-stocks-to-buy-right-now/?source=iedfolrf0000001
Sep 21, 2024 - Bargain hunters should love these great stocks.
0
fool:126987602865807297
0
https://www.fool.com/investing/2024/09/18/3-magnificent-dividend-stocks-with-yields-above-5/?source=iedfolrf0000001
Sep 18, 2024 - After underperforming over the past few years, these stocks offer huge dividend yields that could keep rising throughout your retirement.
0
fool:-5760595904980383515
0
https://www.fool.com/investing/2024/09/13/got-5000-3-dirt-cheap-stocks-to-buy-right-now/?source=iedfolrf0000001
Sep 13, 2024 - These stocks all trade at less than 14 times their expected future profits.
0
fool:3451839851494160150
0
https://www.fool.com/investing/2024/09/13/bull-market-here-2-high-potential-stocks-to-buy/?source=iedfolrf0000001
Sep 13, 2024 - These players have had their ups and downs -- but the future looks bright.
0
fool:-9146075651200381992
0
https://www.zacks.com/stock/news/2334803/pfizer-pfe-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2334803
Sep 11, 2024 - Pfizer (PFE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zc:4156908026865456132
0
https://www.zacks.com/stock/news/2334754/pfe-or-nvo-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2334754
Sep 11, 2024 - PFE vs. NVO: Which Stock Is the Better Value Option?
zc:-9102283571998601993
0
https://www.zacks.com/stock/news/2334138/relay-stock-soars-on-upbeat-data-from-breast-cancer-study?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2334138
Sep 10, 2024 - RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for treating MBC.
zc:8139553000254301704
0